N
BIO icon

Numerai’s Bio-Rad Laboratories Class A BIO Stock Holding History

Numerai’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
+802
New +$227K 0.02% 682
2024
Q3 		– Sell
-1,275
Closed -$348K – 360
2024
Q2 		$348K Buy
1,275
+38
+3% +$11.1K 0.13% 229
2024
Q1 		$428K Buy
1,237
+428
+53% +$141K 0.18% 152
2023
Q4 		$261K Buy
+809
New +$254K 0.09% 202

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Numerai's BIO Position: Q2 2026 in Review

Numerai opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 802 shares worth $235K. The stake represents 0.02% of the portfolio and ranks #682 among its holdings. This is a return to the name: Numerai previously reported a position in BIO as recently as Q2 2024.

Numerai first reported a position in BIO in Q4 2023 and has held it in 4 quarters since. The position peaked at $428K in Q1 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Numerai held 802 shares of Bio-Rad Laboratories Class A worth $235K as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new Numerai position in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.02% of Numerai's portfolio in Q2 2026, its #682 holding.
  • Numerai first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 4 quarters since.
  • Numerai's Bio-Rad Laboratories Class A position peaked at $428K in Q1 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.